Please enable JavaScript to continue using this application.

Compare $BCAX vs $DMRA | Chartloom

Compare

$BCAX vs $DMRA

Bicara Therapeutics Inc · Damora Therapeutics Inc

BCAX

Bicara Therapeutics Inc

DMRA

Damora Therapeutics Inc

Compare $BCAX vs $DMRA

Comparing Bicara Therapeutics Inc and Damora Therapeutics Inc

BCAXBicara Therapeutics Inc

DMRADamora Therapeutics Inc

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

DMRADamora Therapeutics Inc

Market cap

$1.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.4%

52W performance

-17.4%

FCF yield

-3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

DMRA

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

DMRA

Damora Therapeutics Inc

Market Cap

BCAX$1.15B

DMRA$1.30B

Enterprise Value

BCAX$1.05B

DMRA$757M

Price

BCAX$17.50

DMRA$21.08

P/E Ratio

BCAXN/A

DMRAN/A

P/S Ratio

BCAX0.00x

DMRA0.00x

EV/Sales

BCAX0.00x

DMRA0.00x

EV/EBITDA

BCAX0.00x

DMRA0.00x

P/B Ratio

BCAX2.49x

DMRA2.47x

P/FCF Ratio

BCAXN/A

DMRAN/A

EV/FCF

BCAX-7.79x

DMRA-17.00x

PEG Ratio

BCAXN/A

DMRAN/A

Forward P/E (NTM)

BCAXN/A

DMRAN/A

Forward P/S (NTM)

BCAXN/A

DMRAN/A

Revenue (TTM)

BCAX$0

DMRA$0

Revenue Growth (YoY)

BCAXN/A

DMRAN/A

Forward Rev Growth

BCAX1358.6%

DMRA346.9%

Gross Margin (TTM)

BCAX0.0%

DMRA0.0%

Operating Margin (TTM)

BCAX0.0%

DMRA0.0%

EBITDA Margin (TTM)

BCAX0.0%

DMRA0.0%

Net Margin (TTM)

BCAX0.0%

DMRA0.0%

FCF Margin (TTM)

BCAXN/A

DMRAN/A

Net Income (TTM)

BCAX$-185M

DMRA$-265M

FCF (TTM)

BCAX$-135M

DMRA$-45M

EPS (TTM)

BCAX-$2.73

DMRA-$4.34

ROE (TTM)

BCAX-4149.0%

DMRA-8306.0%

ROA (TTM)

BCAX-3859.0%

DMRA-7849.0%

ROIC (TTM)

BCAX-4149.0%

DMRA-8306.0%

Cash

BCAX$97M

DMRA$541M

Debt

BCAX$0

DMRA$0

Net Cash/Debt

BCAX$97M

DMRA$541M

Current Ratio (TTM)

BCAX11.59x

DMRA19.73x

Quick Ratio (TTM)

BCAX11.44x

DMRA19.70x

Debt/Equity (TTM)

BCAX0.00x

DMRA0.00x

Debt/Assets (TTM)

BCAX0.0%

DMRA0.0%

Interest Coverage (TTM)

BCAXN/A

DMRAN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

DMRA0.00x

Beta

BCAX0.94

DMRA-4.05

52W Performance

BCAX-2.8%

DMRA-17.4%

YTD Performance

BCAX6.8%

DMRA-17.4%

% from 52W High

BCAX-43.5%

DMRA-39.6%

% from 52W Low

BCAX27.7%

DMRA27.8%

Asset Turnover (TTM)

BCAX0.00x

DMRA0.00x

FCF Yield (TTM)

BCAX-11.8%

DMRA-3.4%

Earnings Yield (TTM)

BCAX-16.1%

DMRA-20.4%

Dividend Yield (TTM)

BCAXN/A

DMRAN/A

Rule of 40

BCAX0.0

DMRA0.0

EV/GP/RG

BCAXN/A

DMRAN/A

Ticker research

View BCAX research View DMRA research

Metric	BCAX Bicara Therapeutics Inc	DMRA Damora Therapeutics Inc
Market & Valuation
Market Cap	$1.15B	$1.30B
Enterprise Value	$1.05B	$757M
Price	$17.50	$21.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	2.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-17.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	346.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-265M
FCF (TTM)	$-135M	$-45M
EPS (TTM)	-$2.73	-$4.34
ROE (TTM)	-4149.0%	-8306.0%
ROA (TTM)	-3859.0%	-7849.0%
ROIC (TTM)	-4149.0%	-8306.0%
Financial Health
Cash	$97M	$541M
Debt	$0	$0
Net Cash/Debt	$97M	$541M
Current Ratio (TTM)	11.59x	19.73x
Quick Ratio (TTM)	11.44x	19.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	-4.05
52W Performance	-2.8%	-17.4%
YTD Performance	6.8%	-17.4%
% from 52W High	-43.5%	-39.6%
% from 52W Low	27.7%	27.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-3.4%
Earnings Yield (TTM)	-16.1%	-20.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View DMRA research

Valuation

P/S Ratio

BCAX

0.00x

DMRA

0.00x

EV/FCF

DMRA

-17.00x

BCAX

-7.79x

Growth & revenue

Forward Revenue Growth

BCAX

1358.6%

DMRA

346.9%

Profitability & performance

Gross Margin

BCAX

0.0%

DMRA

0.0%

ROE

BCAX

-4149.0%

DMRA

-8306.0%

FCF Yield %

DMRA

-3.4%

BCAX

-11.8%

52-Week Performance

BCAX

-2.8%

DMRA

-17.4%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

DMRA

Damora Therapeutics Inc

Market Cap

BCAX$1.15B

DMRA$1.30B

Enterprise Value

BCAX$1.05B

DMRA$757M

Price

BCAX$17.50

DMRA$21.08

P/E Ratio

BCAXN/A

DMRAN/A

P/S Ratio

BCAX0.00x

DMRA0.00x

EV/Sales

BCAX0.00x

DMRA0.00x

EV/EBITDA

BCAX0.00x

DMRA0.00x

P/B Ratio

BCAX2.49x

DMRA2.47x

P/FCF Ratio

BCAXN/A

DMRAN/A

EV/FCF

BCAX-7.79x

DMRA-17.00x

PEG Ratio

BCAXN/A

DMRAN/A

Forward P/E (NTM)

BCAXN/A

DMRAN/A

Forward P/S (NTM)

BCAXN/A

DMRAN/A

Revenue (TTM)

BCAX$0

DMRA$0

Revenue Growth (YoY)

BCAXN/A

DMRAN/A

Forward Rev Growth

BCAX1358.6%

DMRA346.9%

Gross Margin (TTM)

BCAX0.0%

DMRA0.0%

Operating Margin (TTM)

BCAX0.0%

DMRA0.0%

EBITDA Margin (TTM)

BCAX0.0%

DMRA0.0%

Net Margin (TTM)

BCAX0.0%

DMRA0.0%

FCF Margin (TTM)

BCAXN/A

DMRAN/A

Net Income (TTM)

BCAX$-185M

DMRA$-265M

FCF (TTM)

BCAX$-135M

DMRA$-45M

EPS (TTM)

BCAX-$2.73

DMRA-$4.34

ROE (TTM)

BCAX-4149.0%

DMRA-8306.0%

ROA (TTM)

BCAX-3859.0%

DMRA-7849.0%

ROIC (TTM)

BCAX-4149.0%

DMRA-8306.0%

Cash

BCAX$97M

DMRA$541M

Debt

BCAX$0

DMRA$0

Net Cash/Debt

BCAX$97M

DMRA$541M

Current Ratio (TTM)

BCAX11.59x

DMRA19.73x

Quick Ratio (TTM)

BCAX11.44x

DMRA19.70x

Debt/Equity (TTM)

BCAX0.00x

DMRA0.00x

Debt/Assets (TTM)

BCAX0.0%

DMRA0.0%

Interest Coverage (TTM)

BCAXN/A

DMRAN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

DMRA0.00x

Beta

BCAX0.94

DMRA-4.05

52W Performance

BCAX-2.8%

DMRA-17.4%

YTD Performance

BCAX6.8%

DMRA-17.4%

% from 52W High

BCAX-43.5%

DMRA-39.6%

% from 52W Low

BCAX27.7%

DMRA27.8%

Asset Turnover (TTM)

BCAX0.00x

DMRA0.00x

FCF Yield (TTM)

BCAX-11.8%

DMRA-3.4%

Earnings Yield (TTM)

BCAX-16.1%

DMRA-20.4%

Dividend Yield (TTM)

BCAXN/A

DMRAN/A

Rule of 40

BCAX0.0

DMRA0.0

EV/GP/RG

BCAXN/A

DMRAN/A

Ticker research

View BCAX research View DMRA research

Metric	BCAX Bicara Therapeutics Inc	DMRA Damora Therapeutics Inc
Market & Valuation
Market Cap	$1.15B	$1.30B
Enterprise Value	$1.05B	$757M
Price	$17.50	$21.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	2.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-17.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	346.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-265M
FCF (TTM)	$-135M	$-45M
EPS (TTM)	-$2.73	-$4.34
ROE (TTM)	-4149.0%	-8306.0%
ROA (TTM)	-3859.0%	-7849.0%
ROIC (TTM)	-4149.0%	-8306.0%
Financial Health
Cash	$97M	$541M
Debt	$0	$0
Net Cash/Debt	$97M	$541M
Current Ratio (TTM)	11.59x	19.73x
Quick Ratio (TTM)	11.44x	19.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	-4.05
52W Performance	-2.8%	-17.4%
YTD Performance	6.8%	-17.4%
% from 52W High	-43.5%	-39.6%
% from 52W Low	27.7%	27.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-3.4%
Earnings Yield (TTM)	-16.1%	-20.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View DMRA research